Administration of Recombinant Erythropoietin to a Patient with Malignant Lymphoma Who Refused Blood Transfusion / 輸血拒否例に対する化学療法でのエリスロポエチン併用の試み
- Resource Type
- Journal Article
- Authors
- Atsushi USHIJIMA; Hiromichi NISHIMURA; Kiyoshi TAKATSUKI; Makoto KAWAKITA; 河北 誠; 牛島 淳; 西村 弘道; 高月 清
- Source
- 臨床血液 / Rinsho Ketsueki. 1990, 31(10):1698
- Subject
- Jehovah's Witness
anemia
erythropoietin
malignant lymphoma
- Language
- Japanese
- ISSN
- 0485-1439
1882-0824
A 30-year-old female patient with malignant lymphoma was admitted to the hospital because of large mass in the left pelvic cavity and of severe anemia. Since she had refused blood transfusion (Jehovah's witness), recombinant human erythropoietin (Epo) was used together with both chemotherapy and irradiation; this led to rapid recovery of the anemia and marked reduction of the mass volume. These findings may suggest the possible application of Epo administration as a supportive therapy in treatment of malignancy.